CDKN2A and ovarian mucinous adenocarcinoma: Analyses of focal copy number changes revealed amplifications of CCND1 and ERBB2 and homozygous deletions of CDKN2A/B in mucinous ovarian carcinomas, a finding consistent with previous studies (37, 67–69).